CoChat

A systems biology approach to understanding elevated serum alanine transaminase levels in a clinical trial with ximelagatran

Andersson, Ulf, Lindberg, Johan, Wang, Shunghuang, Balasubramanian, Raji, Marcusson-Ståhl, Maritha, Hannula, Mira, Zeng, Chenhui, Juhasz, Peter J., Kolmert, Johan, Bäckström, Jonas, Nord, Lars, Nilsson, Kerstin, Martin, Steve, Glinghammar, Björn, Cederbrant, Karin, Schuppe-Koistinen, Ina · 2009 · Biomarkers
Cited by 50

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Ximelagatran was developed for the prevention and treatment of thromboembolic conditions. However, in long-term clinical trials with ximelagatran, the liver injury marker, alanine aminotransferase (ALT) increased in some patients. Analysis of plasma samples from 134 patients was carried out using proteomic and metabolomic platforms, with the aim of finding predictive biomarkers to explain the ALT elevation. Analytes that were changed after ximelagatran treatment included 3-hydroxybutyrate, pyruvic acid, CSF1R, Gc-globulin, L-glutamine, protein S and alanine, etc. Two of these analytes (pyruvic acid and CSF1R) were studied further in human cell cultures in vitro with ximelagatran. A systems biology approach applied in this study proved to be successful in generating new hypotheses for an unknown mechanism of toxicity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3109/13547500903261354

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 50

Metadata

Authors
Andersson, U., Lindberg, J., Wang, S., Balasubramanian, R., Marcusson-Ståhl, M., Hannula, M., Zeng, C., Juhasz, P. J., Kolmert, J., Bäckström, J., Nord, L., Nilsson, K., Martin, S., Glinghammar, B., Cederbrant, K., & Schuppe-Koistinen, I.
Venue
Biomarkers
Published
2009-12
Volume
14
Issue
8
Pages
572-586
ISSN
  • 1354-750X (ISSN-L)
  • 1366-5804
OpenAlex
W2037199469
Cited by
50
References
5
FWCI
4.31
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A systems biology approach to understanding elevated serum alanine transaminase levels in a clinical trial with ximelagatran. https://app.cochat.ai/papers/10.3109/13547500903261354
The paper
Andersson, U., Lindberg, J., Wang, S., Balasubramanian, R., Marcusson-Ståhl, M., Hannula, M., Zeng, C., Juhasz, P. J., Kolmert, J., Bäckström, J., Nord, L., Nilsson, K., Martin, S., Glinghammar, B., Cederbrant, K., & Schuppe-Koistinen, I. (2009). A systems biology approach to understanding elevated serum alanine transaminase levels in a clinical trial with ximelagatran. Biomarkers. https://doi.org/10.3109/13547500903261354

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.